First AD

Second AD

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Chronic Lymphocytic Leukemia

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 

Non-Hodgkin Lymphoma

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Mantle Cell Lymphoma

The OncLive Mantle Cell Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on mantle cell lymphoma treatment.  This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, therapeutic advances, and ongoing research in mantle cell lymphoma.

Evolving Treatment Landscape of BTK Inhibitors in B-Cell Malignancies

Insights

Resistance to BTK Inhibitors in B-Cell Malignancies

Diagnosing Waldenstrom Macroglobulinemia

Genomic Profiling in Chronic Lymphocytic Leukemia

Targeting BTK in B-Cell Malignancies

BTK Inhibitors Explored in B-Cell Malignancies

BTK Inhibitors in Waldenstrom Macroglobulinemia

First-Generation BTK Inhibition in Mantle Cell Lymphoma

New and Emerging BTK Inhibitors in Mantle Cell Lymphoma

BTK Inhibitors in Chronic Lymphocytic Leukemia

BTK Combination Strategies for B-Cell Malignancies

Using BTK Inhibitors in Community Practice